JPM - 2023 Preview in Eliquis | BMY Message Board Posts


Bristol-Myers Squibb Co.

  BMY website

BMY   /  Message Board  /  Read Message

 
BOARD

GROUPS
 










Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message board, top of board
Msg  10764 of 10959  at  1/31/2023 10:49:11 AM  by

Biotech2050

The following message was updated on 1/31/2023 10:53:45 AM.

 In response to msg 10762 by  zippypie
view thread

Re: JPM - 2023 Preview in Eliquis

  
Per JPM “We forecast Eliquis sales growing to $12.7bn (+6.6% y/y, -$54mn
vs cons) despite emerging generic competition internationally.”
 
Per Pfizer on their 50% share of Eliquis  Slide 6 = $6.5B for Pfizer share = $13B in total
 
So a $300M beat on Eliquis sales 
 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 6  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message board, top of board




Financial Market Data provided by
.
Loading...